{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T11:04:14Z","timestamp":1793703854156,"version":"4.5.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,8,2]],"date-time":"2020-08-02T00:00:00Z","timestamp":1596326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,2]],"date-time":"2020-08-02T00:00:00Z","timestamp":1596326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s10620-020-06498-7","type":"journal-article","created":{"date-parts":[[2020,8,2]],"date-time":"2020-08-02T11:02:35Z","timestamp":1596366155000},"page":"2439-2451","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Incidence of Hepatocellular Carcinoma in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis"],"prefix":"10.1007","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8885-4507","authenticated-orcid":false,"given":"Yamini","family":"Natarajan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aylin","family":"Tansel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parth","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kingsley","family":"Emologu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richa","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeeshan","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hashem B.","family":"El-Serag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron P.","family":"Thrift","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fasiha","family":"Kanwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,2]]},"reference":[{"key":"6498_CR1","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","volume":"50","author":"KD Lindor","year":"2009","unstructured":"Lindor KD, et al. Primary biliary cirrhosis. Hepatology. 2009;50:291\u2013308.","journal-title":"Hepatology"},{"key":"6498_CR2","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1053\/j.gastro.2008.07.019","volume":"135","author":"P-M Huet","year":"2008","unstructured":"Huet P-M, et al. Portal hypertension and primary biliary cirrhosis: effect of long-term ursodeoxycholic acid treatment. Gastroenterology. 2008;135:1552\u20131560.","journal-title":"Gastroenterology"},{"key":"6498_CR3","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1002\/hep.25788","volume":"56","author":"Y Liang","year":"2012","unstructured":"Liang Y, Yang Z, Zhong R. Primary biliary cirrhosis and cancer risk: a systematic review and meta-analysis. Hepatology. 2012;56:1409\u20131417.","journal-title":"Hepatology"},{"key":"6498_CR4","first-page":"266","volume":"8","author":"K Boonstra","year":"2014","unstructured":"Boonstra K, et al. Increased cancer risk in a large population-based cohort of patients with primary biliary cirrhosis: follow-up for up to 36 years. Hepatol Int. 2014;8:266\u2013274.","journal-title":"Hepatol Int"},{"key":"6498_CR5","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/apt.13448","volume":"43","author":"KA Kim","year":"2016","unstructured":"Kim KA, et al. Population-based epidemiology of primary biliary cirrhosis in South Korea. Aliment Pharmacol Ther. 2016;43:154\u2013162.","journal-title":"Aliment Pharmacol Ther"},{"key":"6498_CR6","doi-asserted-by":"crossref","first-page":"e2537","DOI":"10.1097\/MD.0000000000002537","volume":"95","author":"CT Chen","year":"2016","unstructured":"Chen CT, et al. Increased risks of spontaneous bacterial peritonitis and interstitial lung disease in primary biliary cirrhosis patients with concomitant sj\u00f6gren syndrome. Medicine (Baltimore). 2016;95:e2537.","journal-title":"Medicine (Baltimore)"},{"key":"6498_CR7","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/hep.510260508","volume":"26","author":"DEJ Jones","year":"1997","unstructured":"Jones DEJ, Metcalf JV, Collier JD, Bassendine MF, James OFW. Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomes. Hepatology. 1997;26:1138\u20131142.","journal-title":"Hepatology"},{"key":"6498_CR8","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1002\/hep.26176","volume":"57","author":"K Harada","year":"2013","unstructured":"Harada K, et al. Incidence of and risk factors for hepatocellular carcinoma in primary biliary cirrhosis: national data from Japan. Hepatology. 2013;57:1942\u20131949.","journal-title":"Hepatology"},{"key":"6498_CR9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/gutjnl-2014-308351","volume":"65","author":"PJ Trivedi","year":"2016","unstructured":"Trivedi PJ, et al. Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study. Gut. 2016;65:321\u2013329.","journal-title":"Gut"},{"key":"6498_CR10","doi-asserted-by":"crossref","first-page":"g7647","DOI":"10.1136\/bmj.g7647","volume":"350","author":"L Shamseer","year":"2015","unstructured":"Shamseer L, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;350:g7647.","journal-title":"BMJ"},{"key":"6498_CR11","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JPT Higgins","year":"2003","unstructured":"Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557\u2013560.","journal-title":"BMJ"},{"key":"6498_CR12","volume-title":"Methods for meta-analysis in medical research","author":"AJ Sutton","year":"2002","unstructured":"Sutton AJ, Abrams KR, Jones DR, et al. Methods for meta-analysis in medical research. New York: Wiley; 2002."},{"key":"6498_CR13","first-page":"1160","volume":"96","author":"L Caballer\u00eda","year":"2001","unstructured":"Caballer\u00eda L, et al. Hepatocellular carcinoma in primary biliary cirrhosis: similar incidence to that in hepatitis C virus-related cirrhosis. Am J Gastroenterol. 2001;96:1160\u20131163.","journal-title":"Am J Gastroenterol"},{"key":"6498_CR14","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1002\/hep.510290501","volume":"29","author":"A Floreani","year":"1999","unstructured":"Floreani A, et al. Hepatic and extrahepatic malignancies in primary biliary cirrhosis. Hepatology. 1999;29:1425\u20131428.","journal-title":"Hepatology"},{"key":"6498_CR15","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1002\/hep.23095","volume":"50","author":"A Cavazza","year":"2009","unstructured":"Cavazza A, et al. Incidence, risk factors, and survival of hepatocellular carcinoma in primary biliary cirrhosis: comparative analysis from two centers. Hepatology. 2009;50:1162\u20131168.","journal-title":"Hepatology"},{"key":"6498_CR16","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1478-3231.2010.02366.x","volume":"31","author":"A Floreani","year":"2011","unstructured":"Floreani A, et al. A 35-year follow-up of a large cohort of patients with primary biliary cirrhosis seen at a single centre. Liver Int. 2011;31:361\u2013368.","journal-title":"Liver Int"},{"key":"6498_CR17","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0168-8278(05)80307-1","volume":"21","author":"F Farinati","year":"1994","unstructured":"Farinati F, et al. Hepatocellular carcinoma in primary biliary cirrhosis. J Hepatol. 1994;21:315\u2013316.","journal-title":"J Hepatol"},{"key":"6498_CR18","first-page":"473","volume":"25","author":"A Floreani","year":"1993","unstructured":"Floreani A, et al. Incidence of hepatic and extra-hepatic malignancies in primary biliary cirrhosis (PBC). Ital J Gastroenterol. 1993;25:473\u2013476.","journal-title":"Ital J Gastroenterol"},{"key":"6498_CR19","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1046\/j.1365-2036.2001.01018.x","volume":"15","author":"PM Battezzati","year":"2001","unstructured":"Battezzati PM, et al. Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patients. Aliment Pharmacol Ther. 2001;15:1427\u20131434.","journal-title":"Aliment Pharmacol Ther"},{"key":"6498_CR20","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.2169\/internalmedicine.52.0010","volume":"52","author":"Y Tomiyama","year":"2013","unstructured":"Tomiyama Y, et al. Risk factors for survival and the development of hepatocellular carcinoma in patients with primary biliary cirrhosis. Intern Med. 2013;52:1553\u20131559.","journal-title":"Intern Med"},{"key":"6498_CR21","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1053\/jhep.2002.33157","volume":"35","author":"A Shibuya","year":"2002","unstructured":"Shibuya A, et al. Hepatocellular carcinoma and survival in patients with primary biliary cirrhosis. Hepatology. 2002;35:1172\u20131178.","journal-title":"Hepatology"},{"key":"6498_CR22","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/hep.21472","volume":"45","author":"M Nakamura","year":"2007","unstructured":"Nakamura M, et al. Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis. Hepatology. 2007;45:118\u2013127.","journal-title":"Hepatology"},{"key":"6498_CR23","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/hep.21795","volume":"46","author":"H Jackson","year":"2007","unstructured":"Jackson H, et al. Influence of ursodeoxycholic acid on the mortality and malignancy associated with primary biliary cirrhosis: a population-based cohort study. Hepatology. 2007;46:1131\u20131137.","journal-title":"Hepatology"},{"key":"6498_CR24","first-page":"1495","volume":"22","author":"EMM Kuiper","year":"2010","unstructured":"Kuiper EMM, et al. Relatively high risk for hepatocellular carcinoma in patients with primary biliary cirrhosis not responding to ursodeoxycholic acid. Eur J Gastroenterol Hepatol. 2010;22:1495\u20131502.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"6498_CR25","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/MEG.0b013e3282f163ed","volume":"20","author":"M Deutsch","year":"2008","unstructured":"Deutsch M, Papatheodoridis GV, Tzakou A, Hadziyannis SJ. Risk of hepatocellular carcinoma and extrahepatic malignancies in primary biliary cirrhosis. Eur J Gastroenterol Hepatol. 2008;20:5\u20139.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"6498_CR26","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S1568-9972(02)00050-2","volume":"1","author":"J Findor","year":"2002","unstructured":"Findor J, He X-S, Sord J, Terg R, Gershwin ME. Primary biliary cirrhosis and hepatocellular carcinoma. Autoimmun Rev. 2002;1:220\u2013225.","journal-title":"Autoimmun Rev"},{"key":"6498_CR27","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/hep.24743","volume":"55","author":"JH Ngu","year":"2012","unstructured":"Ngu JH, Gearry RB, Frampton CM, Stedman CAM. Mortality and the risk of malignancy in autoimmune liver diseases: a population-based study in Canterbury. N Z Hepatol. 2012;55:522\u2013529.","journal-title":"N Z Hepatol"},{"key":"6498_CR28","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.cgh.2019.08.013","volume":"18","author":"NK Gatselis","year":"2020","unstructured":"Gatselis NK, et al. Factors associated with progression and outcomes of early stage primary biliary cholangitis. Clin Gastroenterol Hepatol. 2020;18:684\u2013692.e6.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"6498_CR29","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1148\/radiology.220.2.r01au36329","volume":"220","author":"A Blachar","year":"2001","unstructured":"Blachar A, Federle MP, Brancatelli G. Primary biliary cirrhosis: clinical, pathologic, and helical CT findings in 53 patients. Radiology. 2001;220:329\u2013336.","journal-title":"Radiology"},{"key":"6498_CR30","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1309\/AJCPQV4A7QAEEFEV","volume":"144","author":"MM Tana","year":"2015","unstructured":"Tana MM, et al. The significance of autoantibody changes over time in primary biliary cirrhosis. Am J Clin Pathol. 2015;144:601\u2013606.","journal-title":"Am J Clin Pathol"},{"key":"6498_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MD.0000000000004558","volume":"95","author":"C Chen","year":"2016","unstructured":"Chen C, Tseng Y, Yang C, Lin H. Increased risks of spontaneous bacterial peritonitis and interstitial lung disease in primary biliary cirrhosis patients with concomitant sjogren syndrome. Medicine. 2016;95:1\u20137.","journal-title":"Medicine"},{"key":"6498_CR32","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1111\/j.1572-0241.2005.50007.x","volume":"100","author":"GLH Wong","year":"2005","unstructured":"Wong GLH, et al. A retrospective study on clinical features and prognostic factors of biopsy-proven primary biliary cirrhosis in Chinese patients. Am J Gastroenterol. 2005;100:2205\u20132211.","journal-title":"Am J Gastroenterol"},{"key":"6498_CR33","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/0002-9343(84)90861-1","volume":"76","author":"AM Wolke","year":"1984","unstructured":"Wolke AM, Schaffner F, Kapelman B, Sacks HS. Malignancy in primary biliary cirrhosis. High incidence of breast cancer in affected women. Am J Med. 1984;76:1075\u20131078.","journal-title":"Am J Med"},{"key":"6498_CR34","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.3748\/wjg.v21.i12.3554","volume":"21","author":"XX Zhang","year":"2015","unstructured":"Zhang XX, et al. Primary biliary cirrhosis-associated hepatocellular carcinoma in Chinese patients: incidence and risk factors. World J Gastroenterol. 2015;21:3554\u20133563.","journal-title":"World J Gastroenterol"},{"key":"6498_CR35","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s12016-015-8483-x","volume":"48","author":"G Rong","year":"2015","unstructured":"Rong G, et al. Incidence and risk factors for hepatocellular carcinoma in primary biliary cirrhosis. Clin Rev Allergy Immunol. 2015;48:132\u2013141.","journal-title":"Clin Rev Allergy Immunol"},{"key":"6498_CR36","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/hep.1840200116","volume":"20","author":"L L\u00f6\u00f6f","year":"1994","unstructured":"L\u00f6\u00f6f L, et al. Cancer risk in primary biliary cirrhosis: a population-based study from Sweden. Hepatology. 1994;20:101\u2013104.","journal-title":"Hepatology"},{"key":"6498_CR37","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1038\/ctg.2017.23","volume":"8","author":"K-S Cheung","year":"2017","unstructured":"Cheung K-S, Seto W-K, Fung J, Lai C-L, Yuen M-F. Prognostic factors for transplant-free survival and validation of prognostic models in chinese patients with primary biliary cholangitis receiving ursodeoxycholic acid. Clin Transl Gastroenterol. 2017;8:e100.","journal-title":"Clin Transl Gastroenterol"},{"key":"6498_CR38","doi-asserted-by":"crossref","first-page":"e116","DOI":"10.1038\/ctg.2017.43","volume":"8","author":"K-S Cheung","year":"2017","unstructured":"Cheung K-S, Seto W-K, Fung J, Lai C-L, Yuen M-F. Epidemiology and natural history of primary biliary cholangitis in the chinese: a territory-based study in Hong Kong between 2000 and 2015. Clin Transl Gastroenterol. 2017;8:e116.","journal-title":"Clin Transl Gastroenterol"},{"key":"6498_CR39","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejim.2017.05.006","volume":"42","author":"NK Gatselis","year":"2017","unstructured":"Gatselis NK, et al. Geoepidemiology, clinical manifestations and outcome of primary biliary cholangitis in Greece. Eur J Intern Med. 2017;42:81\u201388.","journal-title":"Eur J Intern Med"},{"key":"6498_CR40","doi-asserted-by":"crossref","first-page":"168012","DOI":"10.1155\/2013\/168012","volume":"2013","author":"K Hosonuma","year":"2013","unstructured":"Hosonuma K, et al. Incidence, mortality, and predictive factors of hepatocellular carcinoma in primary biliary cirrhosis. Gastroenterol Res Pract. 2013;2013:168012.","journal-title":"Gastroenterol Res Pract"},{"key":"6498_CR41","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1148\/radiol.2263011737","volume":"226","author":"E Caturelli","year":"2003","unstructured":"Caturelli E, et al. Coarse nodular US pattern in hepatic cirrhosis: risk for hepatocellular carcinoma. Radiology. 2003;226:691\u2013697.","journal-title":"Radiology"},{"key":"6498_CR42","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/j.1478-3231.2008.01715.x","volume":"28","author":"CW Su","year":"2008","unstructured":"Su CW, et al. Natural history and prognostic factors of primary biliary cirrhosis in Taiwan: a follow-up study up to 18 years. Liver Int. 2008;28:1305\u20131313.","journal-title":"Liver Int"},{"key":"6498_CR43","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S1568-9972(02)00050-2","volume":"1","author":"J Findor","year":"2002","unstructured":"Findor J, He X, Sord J, Terg R, Gershwin ME. Primary biliary cirrhosis and hepatocellular carcinoma. Autoim Rev. 2002;1:220\u2013225.","journal-title":"Autoim Rev"},{"key":"6498_CR44","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/j.1365-2036.2004.01963.x","volume":"19","author":"OS Lin","year":"2004","unstructured":"Lin OS, Keeffe EB, Sanders GD, Owens DK. Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C. Aliment Pharmacol Ther. 2004;19:1159\u20131172.","journal-title":"Aliment Pharmacol Ther"},{"key":"6498_CR45","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1572-0241.2003.07327.x","volume":"98","author":"MR Arguedas","year":"2003","unstructured":"Arguedas MR, Chen VK, Eloubeidi MA, Fallon MB. Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost-utility analysis. Am J Gastroenterol. 2003;98:679\u2013690.","journal-title":"Am J Gastroenterol"},{"key":"6498_CR46","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1053\/j.gastro.2004.09.014","volume":"127","author":"G Fattovich","year":"2004","unstructured":"Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology. 2004;127:S35\u2013S50.","journal-title":"Gastroenterology"},{"key":"6498_CR47","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jhep.2015.01.002","volume":"62","author":"GV Papatheodoridis","year":"2015","unstructured":"Papatheodoridis GV, Chan HLY, Hansen BE, Janssen HLA, Lampertico P. Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy. J Hepatol. 2015;62:956\u2013967.","journal-title":"J Hepatol"},{"key":"6498_CR48","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.cgh.2017.02.006","volume":"15","author":"A Tansel","year":"2017","unstructured":"Tansel A, et al. Incidence and determinants of hepatocellular carcinoma in autoimmune hepatitis: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2017;15:1207\u20131217.e4.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"6498_CR49","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1007\/s10620-010-1444-6","volume":"56","author":"RJ Wong","year":"2011","unstructured":"Wong RJ, Gish R, Frederick T, Bzowej N, Frenette C. Development of hepatocellular carcinoma in autoimmune hepatitis patients: a case series. Dig Dis Sci. 2011;56:578\u2013585. https:\/\/doi.org\/10.1007\/s10620-010-1444-6.","journal-title":"Dig Dis Sci"},{"key":"6498_CR50","doi-asserted-by":"crossref","first-page":"578","DOI":"10.3748\/wjg.15.578","volume":"15","author":"A Teufel","year":"2009","unstructured":"Teufel A, et al. Hepatocellular carcinoma in patients with autoimmune hepatitis. World J Gastroenterol. 2009;15:578\u2013582.","journal-title":"World J Gastroenterol"},{"key":"6498_CR51","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0002-9343(96)00197-0","volume":"101","author":"FP Sarasin","year":"1996","unstructured":"Sarasin FP, Giostra E, Hadengue A. Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with child-pugh class A cirrhosis. Am J Med. 1996;101:422\u2013434.","journal-title":"Am J Med"}],"updated-by":[{"DOI":"10.1007\/s10620-020-06619-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T00:00:00Z","timestamp":1601337600000}}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-020-06498-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-020-06498-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-020-06498-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T23:36:41Z","timestamp":1627861001000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-020-06498-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,2]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["6498"],"URL":"https:\/\/doi.org\/10.1007\/s10620-020-06498-7","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s10620-020-06619-2","asserted-by":"object"}]},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,2]]},"assertion":[{"value":"3 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2020","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s10620-020-06619-2","URL":"https:\/\/doi.org\/10.1007\/s10620-020-06619-2","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no conflict of interest. The views expressed in this article are those of the authors and do not necessarily represent the views of the Department of Veterans Affairs or the National Institute of Diabetes Digestive and Kidney Diseases.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}